<DOC>
	<DOCNO>NCT01244035</DOCNO>
	<brief_summary>This two part study comprise sequential double-dummy , placebo control 3-period randomize crossover study . The study evaluate safety , tolerability , pharmacokinetics , pharmacodynamics different dos dose regimens MK-8266 .</brief_summary>
	<brief_title>A Study Safety , Pharmacodynamics , Pharmacokinetics Different Dosing Regimens MK-8266 Participants With Hypertension ( MK-8266-008 AM1 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Participant essential hypertension grade 1 2 hypertension accord European Society Hypertension ( ESH ) delineate European Society Cardiology ( ESC ) 2007 guideline , i.e . systolic blood pressure value 140179 diastolic blood pressure value 90109 least 3 occasion prior study . Otherwise healthy participant grade 1 2 arterial hypertension treat single antihypertensive drug meet blood pressure criterion may enrol discretion investigator Participant generally good health exception hypertension Participant nonsmoker and/or use nicotine nicotinecontaining product 6 month Participant history illness might confound result study pose additional risk participant take part study Participant history stroke , chronic seizure , major neurological disorder Participant disability interfere rise semirecumbent position stand position Participant personal family history bleed clot disorder Participant history frequent nosebleed recurrent active gingivitis Participant history cancer , except 1 ) certain skin cancer ; 2 ) cancer successfully treat 10 year prior study recur ; , 3 ) participant unlikely recurrence study Participant history cardiac disease include limited heart valve disease evidence secondary cardiac damage Participant categorize class II great accord New York Heart Association ( NYHA ) functional classification heart failure Participant unable refrain use prescription nonprescription drug herbal remedy ( St. John 's Wort ) study Participant anticipate use phosphodiesterase ( PDE5 ) inhibitor [ sildenafil ( Viagra® ) , tadalafil ( Cialis® ) , vardenafil ( Levitra® ) ] study Participant consume excessive amount alcohol ( 3 drink per day ) caffeine ( 6 serving day ) Participant major surgery , donate lose 1 unit blood , participate another investigational within 4 week prior study Participant history multiple and/or severe allergy , anaphylactic reaction intolerance drug food</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>High blood pressure</keyword>
</DOC>